ClinConnect ClinConnect Logo
Search / Trial NCT02757872

Effects of Vitamin D and Fish Oil on the Kidney in Hypertensives

Launched by ALBERT EINSTEIN COLLEGE OF MEDICINE · Apr 28, 2016

Trial Information

Current as of July 01, 2025

Completed

Keywords

Hypertension Kidney Diseases Vitamin D Omega 3 Fatty Acids

ClinConnect Summary

This ancillary study to the VITamin D and OmegA-3 TriaL (VITAL) will test whether vitamin D3, omega-3 fatty acids, or both prevent the development and progression of kidney disease in participants with hypertension. Persons with hypertension are at high risk of kidney disease.

Vitamin D and omega-3 fatty acids are promising interventions for kidney disease prevention and treatment, based on results of animal-experimental models and early human studies. Because these interventions are relatively safe, inexpensive, and widely available, they may offer opportunity to substantially reduce the ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Participants in VITAL (NCT01169259) with a self-reported physician diagnosis of hypertension are eligible to participate in this ancillary study
  • Exclusion Criteria:
  • Diagnosis of diabetes mellitus

About Albert Einstein College Of Medicine

Albert Einstein College of Medicine is a leading academic institution dedicated to advancing biomedical research and medical education. Situated in the Bronx, New York, it is renowned for its commitment to innovative research and training the next generation of physicians and scientists. The college actively engages in a wide range of clinical trials, focusing on translating scientific discoveries into effective therapies and improving patient care. With a collaborative approach that involves multidisciplinary teams, Albert Einstein College of Medicine aims to address significant health challenges and contribute to the global medical community through rigorous research and evidence-based practices.

Locations

Boston, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

Michal L Melamed, MD, MHS

Principal Investigator

Albert Einstein College of Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials